Preferred Urinary Pain Relief Product Recalled for Improper Storage Conditions
Family Dollar Stores is recalling Preferred Urinary Pain Relief Max Strength due to CGMP violations involving improper storage temperature. Product was distributed nationwide April 30 through June 10, 2022.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This FDA Class II recall involves a CGMP violation for improper storage temperature conditions. No illnesses or injuries have been reported. The recall appears precautionary based on manufacturing practice deviations rather than evidence of actual harm to consumers.
Plain-English summary
Family Dollar Stores, LLC is recalling Preferred Urinary Pain Relief Max Strength 12 CT due to Current Good Manufacturing Practice (CGMP) deviations.
The product was held outside appropriate storage temperature conditions during distribution. This violation of proper storage requirements may compromise product integrity and efficacy.
The affected product was distributed nationwide to specific Family Dollar Stores locations from April 30, 2022 through June 10, 2022, identified by SKU 900754.
Consumers who have purchased this product should discontinue use and return it to a Family Dollar Stores location for a refund or replacement.
The recalled product
- Product
- PREFERRED URINRY PN RLF MAX STRNGTH 12 CT distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Urinary Pain Relief
- Hazard
- improper-storage
- temperature-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 900754
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27